نتایج جستجو برای: flt3 itd

تعداد نتایج: 4119  

Journal: :Blood 2011
Mark Levis

Acute myeloid leukemia with a FLT3 internal tandem duplication (FLT3/ITD) mutation is an aggressive hematologic malignancy with a generally poor prognosis. It can be successfully treated into remission with intensive chemotherapy, but it routinely relapses. At relapse, the blasts tend to have higher mutant allelic ratios and, in vitro, are more addicted to the aberrant signaling from the FLT3/I...

2009
Dirk Schmidt-Arras Sylvia-Annette Böhmer Sina Koch Jörg P. Müller Lutz Blei Hauke Cornils Reinhard Bauer Sridhar Korasikha Christian Thiede Frank-D. Böhmer

The mechanism of cell transformation by Fms-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia (AML) is incompletely understood. The most prevalent activated mutant FLT3 ITD exhibits an altered signaling quality, including strong activation of the STAT5 transcription factor. FLT3 ITD has also been found partially retained as a highmannose precursor in an intracellular compartment. To analy...

2017
Adam J Mead Wen Hao Neo Nikolaos Barkas Sahoko Matsuoka Alice Giustacchini Raffaella Facchini Supat Thongjuea Lauren Jamieson Christopher A G Booth Nicholas Fordham Cristina Di Genua Deborah Atkinson Onima Chowdhury Emmanouela Repapi Nicki Gray Shabnam Kharazi Sally-Ann Clark Tiphaine Bouriez Petter Woll Toshio Suda Claus Nerlov Sten Eirik W Jacobsen

Although previous studies suggested that the expression of FMS-like tyrosine kinase 3 (Flt3) initiates downstream of mouse hematopoietic stem cells (HSCs), FLT3 internal tandem duplications (FLT3 ITDs) have recently been suggested to intrinsically suppress HSCs. Herein, single-cell interrogation found Flt3 mRNA expression to be absent in the large majority of phenotypic HSCs, with a strong nega...

Journal: :Blood 2001
P D Kottaridis R E Gale M E Frew G Harrison S E Langabeer A A Belton H Walker K Wheatley D T Bowen A K Burnett A H Goldstone D C Linch

In acute myeloid leukemia (AML), further prognostic determinants are required in addition to cytogenetics to predict patients at increased risk of relapse. Recent studies have indicated that an internal tandem duplication (ITD) in the FLT3 gene may adversely affect clinical outcome. This study evaluated the impact of a FLT3/ITD mutation on outcome in 854 patients, mostly 60 years of age or youn...

2015
Genevra Pillinger Amina Abdul-Aziz Lyubov Zaitseva Matthew Lawes David J. MacEwan Kristian M. Bowles Stuart A. Rushworth

Approximately 20% of patients with acute myeloid leukaemia (AML) have a mutation in FMS-like-tyrosine-kinase-3 (FLT3). FLT3 is a trans-membrane receptor with a tyrosine kinase domain which, when activated, initiates a cascade of phosphorylated proteins including the SRC family of kinases. Recently our group and others have shown that pharmacologic inhibition and genetic knockdown of Bruton's ty...

Hossein Ayatollahi, Hossein Rahimi, Mohammad Hadi Sadeghian, Mohammad Mehdi Kooshyar, Mohammad Reza Keramati, Sepideh Shakeri, Seyyede Fatemeh Shams,

Background and Aims: Multiple myeloma is a malignant proliferation of plasma cells derived from a single clone. The tumor, its products and the host response lead to organ damages. Some factors that are responsible in its pathogenesis are recognized. As FMS like Tyrosine Kinase 3 receptor (FLT3) mutation has been proved as a determining factor in leukemic patients the goal of this study was to ...

Journal: :CoRR 2017
Christine A. Liang Lei Chen Amer Wahed Andy N. D. Nguyen

Deep Learning can significantly benefit cancer proteomics and genomics. In this study, we attempt to determine a set of critical proteins that are associated with the FLT3-ITD mutation in newly-diagnosed acute myeloid leukemia patients. A Deep Learning network consisting of autoencoders forming a hierarchical model from which high-level features are extracted without labeled training data. Dime...

Background and Objective: Identification of cytogenetic and molecular changes plays an important role in acute myeloid leukemia (AML) patients. Thus, they are used in classification, prognosis and treatment of the disease. The CD123 expression and FLT3 gene mutations are also the variations that may assist in prognosis and treatment of patients with AML.Methods:</...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Marianne Bienz Madleina Ludwig Elisabeth Oppliger Leibundgut Beatrice U Mueller Daniel Ratschiller Max Solenthaler Martin F Fey Thomas Pabst

PURPOSE The recognition of a number of leukemia-specific cytogenetic abnormalities and their role as independent prognostic factors have provided considerable insights into leukemia pathogenesis and have paved the way to adopt risk-adapted treatment. However, approximately 50% of newly diagnosed acute myeloid leukemia (AML) have a normal karyotype. There has therefore been much interest in iden...

2017
Jennifer N. Moloney Ashok Kumar Jayavelu Joanna Stanicka Sarah L. Roche Rebecca L. O'Brien Sebastian Scholl Frank-D. Böhmer Thomas G. Cotter

Internal tandem duplication of the juxtamembrane domain of FMS-like tyrosine kinase 3 (FLT3-ITD) is the most prevalent genetic aberration present in 20-30% of acute myeloid leukaemia (AML) cases and is associated with a poor prognosis. FLT3-ITD expressing cells express elevated levels of NADPH oxidase 4 (NOX4)-generated pro-survival hydrogen peroxide (H2O2) contributing to increased levels of D...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید